Laser-Assisted ENT Surgeries Market is expected to reach US$ 513.78 Million by 2031

Equipment Segment to Bolster Laser-Assisted ENT Surgeries Market Growth During 2023–2031

According to our new research study on "Laser-Assisted ENT Surgeries Market Forecast to 2031 – Global Analysis – by Laser Type, Surgery, and End User," the market was valued at US$ 254.14 million in 2023 and is expected to reach US$ 513.78 million by 2031; it is estimated to record a CAGR of 9.2% during 2023–2031. The laser-assisted ENT surgeries market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth. Key factors driving the laser-assisted ENT surgeries market growth include the increasing prevalence of ENT disorders and rising demand for outpatient procedures. However, high costs of equipment restrict the market growth. Further, the integration of smart technologies with laser-assisted ENT surgeries is expected to bring new laser-assisted ENT surgeries market trends in the coming years.

Growing Demand for Outpatient Procedures Bolsters Laser-Assisted ENT Surgeries Market

As healthcare systems worldwide increasingly prioritize outpatient care, the landscape of surgical interventions is evolving, with laser-assisted surgeries emerging as a preferred option for many ENT conditions. This shift is driven by several factors, including advancements in medical technology, patient preferences for convenience and reduced recovery times, and the economic benefits of outpatient procedures. Lasers, such as carbon dioxide (CO?) lasers and Nd:YAG lasers, are widely used in various ENT surgeries, including the treatment of chronic sinusitis, tonsillectomies, and the removal of tumors. These lasers allow for precise tissue targeting, minimizing damage to surrounding areas and significantly reducing postoperative complications. As a result, many procedures that once required hospitalization can now be performed in outpatient settings, aligning with the growing preference for minimally invasive techniques.

Laser-Assisted ENT Surgeries Market  Share, by Region, 2023 (%)

Source: The Insight Partners Analysis

Patients are increasingly seeking outpatient procedures due to the numerous advantages they offer. Outpatient surgeries typically involve shorter recovery times, allowing patients to return to their daily activities more quickly. This is particularly appealing in the fast-paced world, where individuals are often reluctant to take extended time off work or disrupt their personal lives for medical procedures. Laser-assisted surgeries, with their reduced recovery periods and lower risk of complications, fit perfectly into this demand. Patients appreciate the ability to undergo treatment and return home the same day, which enhances their overall experience and satisfaction with the healthcare system.

Changes in healthcare policies and reimbursement models drive a shift toward outpatient procedures. Many insurance providers now favor outpatient surgeries due to their cost-effectiveness and positive patient outcomes. This shift in reimbursement strategies encourages healthcare providers to adopt laser-assisted techniques, as they can offer high-quality care while meeting the financial incentives set forth by insurers. As reimbursement policies evolve, the laser-assisted ENT surgeries market will likely benefit from increased adoption and utilization of these procedures. According to the American Academy of Otolaryngology—Head and Neck Surgery Foundation, average direct laryngoscopy with laser (DLL) reimbursement was US$ 6,453.44 per case, including hospital, anesthesiologist, and surgeon reimbursements of US$ 5,150, US$ 745.66, and US$ 357.78, respectively. As a result, the growing demand for outpatient procedures positively bolsters the laser-assisted ENT surgeries market size..

The laser-assisted ENT surgeries market analysis has been carried out by considering the following segments: laser type, surgery type, end user, and geography. The laser-assisted ENT surgeries market, based on laser type, is divided into CO₂ laser, Nd:YAG laser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO₂ laser segment held the largest share of the laser-assisted ENT surgeries market in 2023, and it is expected to register a higher CAGR during 2023–2031. CO? lasers used in ENT have received various regulatory approvals. For instance, the OmniGuide OTO-U CO? laser system, specifically designed for ENT and otology surgeries, received FDA clearance in January 2021. This approval allows for enhanced access in tighter surgical spaces, improving procedural outcomes for surgeons. Additionally, the increasing prevalence of ENT disorders is propelling the demand for effective treatment options, thereby expanding the market for CO? laser devices. As more healthcare facilities adopt these technologies, the market is expected to benefit from a surge in surgical and cosmetic applications, which intensifies the role of CO? laser as a critical tool in modern ENT practices.

The market, based on surgery type, is segmented into laser laryngeal surgery, laser endoscopic sinus surgery (LESS), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinates reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest laser-assisted ENT surgeries market share in 2023. Laser-assisted tonsillectomy and adenoidectomy have increasingly penetrated the surgical landscape as effective alternatives to traditional methods. This shift is primarily driven by the advantages of laser technology, including reduced postoperative pain, decreased bleeding, and shorter recovery times. These benefits have made laser-assisted procedures appealing to patients and healthcare providers, leading to a growing acceptance and adoption in clinical practice. The penetration of laser-assisted techniques into the market is reflected in the rising number of procedures performed annually. As per the National Institute of Health (NIH), in the US alone, over 500,000 tonsillectomies are performed yearly, primarily in children aged under 15, often due to conditions such as sleep-disordered breathing and recurrent throat infections. As awareness of the benefits of laser-assisted surgery increases, the proportion of these procedures performed using laser technology is expected to continue to grow.

The geographic scope of the laser-assisted ENT surgeries market report includes the assessment of the market performance in North America, Europe, Asia Pacific, Middle East and Africa, South and Central America. North America accounted for the largest laser-assisted ENT surgeries market share in 2023. The Sylvester Comprehensive Cancer Center was the first in the US to use the 445-nm blue laser for early glottic cancer treatment, the most common type of laryngeal cancer. There are approximately 2,000 otologists in the US. Many of them use 532-nm laser systems to perform stapedectomy and stapedotomy procedures to correct certain types of hearing loss. In the US, several FDA-approved ENT laser devices, notably CO? laser devices, are widely used in procedures such as adenoidectomy and laryngeal surgery due to their precision and minimal thermal damage to surrounding tissues. Further, Nd:YAG laser systems are diode lasers that are commonly used to treat conditions such as nasal obstruction and perform laser-assisted uvulopalatoplasty. The US Food and Drug Administration has also cleared BIOLASE's EPIC 10 soft-tissue lasers for ENT surgical procedures. As more healthcare facilities adopt FDA-approved lasers, patient outcomes are likely to improve through reduced recovery times and enhanced procedural accuracy. The FDA's approval of these devices is crucial, ensuring they meet stringent safety and efficacy standards along with fostering confidence among healthcare providers and patients.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com